Triple
T6730958
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Teenage Mutant Ninja Turtles (2012 TV series) |
E153631
|
entity |
| Predicate | developer |
P73
|
FINISHED |
| Object | Joshua Sternin |
E624765
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Joshua Sternin | Statement: [Teenage Mutant Ninja Turtles (2012 TV series), developer, Joshua Sternin]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Joshua Sternin Context triple: [Teenage Mutant Ninja Turtles (2012 TV series), developer, Joshua Sternin]
-
A.
Joshua Sternin
chosen
Joshua Sternin is an American television writer and producer known for his work on animated and live-action series, including co-creating the 2012 Teenage Mutant Ninja Turtles TV adaptation.
-
B.
Joshua Michael Stern
Joshua Michael Stern is an American film director and screenwriter known for helming biographical and dramatic feature films.
-
C.
Jared Stern
Jared Stern is an American screenwriter, producer, and director known for his work on animated films such as DC League of Super-Pets and contributions to various family-oriented comedies.
-
D.
Joshua Jortner
Joshua Jortner is an Israeli physical chemist renowned for his pioneering work in molecular dynamics and chemical physics, and for his influential role in advancing Israel’s scientific community.
-
E.
Joshua Bilenker
Joshua Bilenker is an American oncologist and biotech executive best known for founding and leading Loxo Oncology, a precision medicine company focused on targeted cancer therapies.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c6880bdd68819097de8b6099992682 |
completed | March 27, 2026, 1:37 p.m. |
| NER | Named-entity recognition | batch_69c6d16a30888190ae474d90bb71ac49 |
completed | March 27, 2026, 6:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c748994250819092ba9bf4fd3f5b90 |
completed | March 28, 2026, 3:18 a.m. |
Created at: March 27, 2026, 2:09 p.m.